DONNA YANUSZ: Open Payments
NPI 1902855349 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,198 in 131 payments from 19 companies in 2025. Trend: 2023 $1,228 · 2024 $1,511 · 2025 $2,198
Food & beverage: $2,091Education: $107
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $320 |
| Janssen Biotech, Inc. | 4 | $267 |
| Organon LLC | 26 | $217 |
| Regeneron Healthcare Solutions, Inc. | 7 | $205 |
| Lilly USA, LLC | 13 | $194 |
| Galderma Laboratories, L.P. | 8 | $191 |
| ABBVIE INC. | 18 | $185 |
| PFIZER INC. | 11 | $152 |
| Amgen Inc. | 5 | $86 |
| Almirall LLC | 5 | $77 |
Products named: Bimzelx, TREMFYA, DUPIXENT, NEMLUVIO, SKYRIZI, TALTZ, CIBINQO, OTEZLA.
Industry payments across NJ — which companies pay providers there.
